 | • レポートコード：MRC2-11QY11629 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病治療のグローバル市場について調査・分析したレポートです。種類別（インスリン、経口血糖降下薬、非インスリン注射薬、その他）市場規模、用途別（病院、個人、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病治療の競争状況、市場シェア ・世界の糖尿病治療市場：種類別市場規模 2015年-2020年（インスリン、経口血糖降下薬、非インスリン注射薬、その他） ・世界の糖尿病治療市場：種類別市場規模予測 2021年-2026年（インスリン、経口血糖降下薬、非インスリン注射薬、その他） ・世界の糖尿病治療市場：用途別市場規模 2015年-2020年（病院、個人、クリニック） ・世界の糖尿病治療市場：用途別市場規模予測 2021年-2026年（病院、個人、クリニック） ・北米の糖尿病治療市場分析：米国、カナダ ・ヨーロッパの糖尿病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、Bayer、Teva Pharmaceuticals、Merck＆Company、Medtronic、Johnson＆Johnson、Home Diagnostics、Amylin Pharmaceuticals、Abbott Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved people’s living habits, disease control effect, is becoming more and more important.
Market Analysis and Insights: Global Diabetes Treatment Market
The global Diabetes Treatment market size is projected to reach US$ 9735.2 million by 2026, from US$ 9412 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Diabetes Treatment Scope and Market Size
Diabetes Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novo Nordisk
Bayer
Teva Pharmaceuticals
Merck＆Company
Medtronic
Johnson＆Johnson
Home Diagnostics
Amylin Pharmaceuticals
Abbott Laboratories
Market segment by Type, the product can be split into
Insulin
Oral Hypoglycaemic Drugs
Non-Insulin Injectable Drugs
Others
Market segment by Application, split into
Hospital
Personal Use
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Treatment Revenue
1.4 Market by Type
1.4.1 Global Diabetes Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insulin
1.4.3 Oral Hypoglycaemic Drugs
1.4.4 Non-Insulin Injectable Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Diabetes Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Personal Use
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Treatment Market Perspective (2015-2026)
2.2 Global Diabetes Treatment Growth Trends by Regions
2.2.1 Diabetes Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Treatment Players by Market Size
3.1.1 Global Top Diabetes Treatment Players by Revenue (2015-2020)
3.1.2 Global Diabetes Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Treatment Market Concentration Ratio
3.2.1 Global Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Revenue in 2019
3.3 Diabetes Treatment Key Players Head office and Area Served
3.4 Key Players Diabetes Treatment Product Solution and Service
3.5 Date of Enter into Diabetes Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetes Treatment Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetes Treatment Market Size by Application (2015-2020)
5.2 Global Diabetes Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetes Treatment Market Size (2015-2020)
6.2 Diabetes Treatment Key Players in North America (2019-2020)
6.3 North America Diabetes Treatment Market Size by Type (2015-2020)
6.4 North America Diabetes Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetes Treatment Market Size (2015-2020)
7.2 Diabetes Treatment Key Players in Europe (2019-2020)
7.3 Europe Diabetes Treatment Market Size by Type (2015-2020)
7.4 Europe Diabetes Treatment Market Size by Application (2015-2020)
8 China
8.1 China Diabetes Treatment Market Size (2015-2020)
8.2 Diabetes Treatment Key Players in China (2019-2020)
8.3 China Diabetes Treatment Market Size by Type (2015-2020)
8.4 China Diabetes Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetes Treatment Market Size (2015-2020)
9.2 Diabetes Treatment Key Players in Japan (2019-2020)
9.3 Japan Diabetes Treatment Market Size by Type (2015-2020)
9.4 Japan Diabetes Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetes Treatment Market Size (2015-2020)
10.2 Diabetes Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Treatment Market Size by Application (2015-2020)
11 India
11.1 India Diabetes Treatment Market Size (2015-2020)
11.2 Diabetes Treatment Key Players in India (2019-2020)
11.3 India Diabetes Treatment Market Size by Type (2015-2020)
11.4 India Diabetes Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetes Treatment Market Size (2015-2020)
12.2 Diabetes Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Treatment Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Details
13.1.2 Novo Nordisk Business Overview
13.1.3 Novo Nordisk Diabetes Treatment Introduction
13.1.4 Novo Nordisk Revenue in Diabetes Treatment Business (2015-2020))
13.1.5 Novo Nordisk Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Diabetes Treatment Introduction
13.2.4 Bayer Revenue in Diabetes Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Details
13.3.2 Teva Pharmaceuticals Business Overview
13.3.3 Teva Pharmaceuticals Diabetes Treatment Introduction
13.3.4 Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020)
13.3.5 Teva Pharmaceuticals Recent Development
13.4 Merck＆Company
13.4.1 Merck＆Company Company Details
13.4.2 Merck＆Company Business Overview
13.4.3 Merck＆Company Diabetes Treatment Introduction
13.4.4 Merck＆Company Revenue in Diabetes Treatment Business (2015-2020)
13.4.5 Merck＆Company Recent Development
13.5 Medtronic
13.5.1 Medtronic Company Details
13.5.2 Medtronic Business Overview
13.5.3 Medtronic Diabetes Treatment Introduction
13.5.4 Medtronic Revenue in Diabetes Treatment Business (2015-2020)
13.5.5 Medtronic Recent Development
13.6 Johnson＆Johnson
13.6.1 Johnson＆Johnson Company Details
13.6.2 Johnson＆Johnson Business Overview
13.6.3 Johnson＆Johnson Diabetes Treatment Introduction
13.6.4 Johnson＆Johnson Revenue in Diabetes Treatment Business (2015-2020)
13.6.5 Johnson＆Johnson Recent Development
13.7 Home Diagnostics
13.7.1 Home Diagnostics Company Details
13.7.2 Home Diagnostics Business Overview
13.7.3 Home Diagnostics Diabetes Treatment Introduction
13.7.4 Home Diagnostics Revenue in Diabetes Treatment Business (2015-2020)
13.7.5 Home Diagnostics Recent Development
13.8 Amylin Pharmaceuticals
13.8.1 Amylin Pharmaceuticals Company Details
13.8.2 Amylin Pharmaceuticals Business Overview
13.8.3 Amylin Pharmaceuticals Diabetes Treatment Introduction
13.8.4 Amylin Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020)
13.8.5 Amylin Pharmaceuticals Recent Development
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Details
13.9.2 Abbott Laboratories Business Overview
13.9.3 Abbott Laboratories Diabetes Treatment Introduction
13.9.4 Abbott Laboratories Revenue in Diabetes Treatment Business (2015-2020)
13.9.5 Abbott Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetes Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Treatment Revenue
Table 3. Ranking of Global Top Diabetes Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insulin
Table 6. Key Players of Oral Hypoglycaemic Drugs
Table 7. Key Players of Non-Insulin Injectable Drugs
Table 8. Key Players of Others
Table 9. Global Diabetes Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Diabetes Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Diabetes Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Diabetes Treatment Market Share by Regions (2015-2020)
Table 13. Global Diabetes Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Diabetes Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Diabetes Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Diabetes Treatment Players
Table 20. Global Diabetes Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Diabetes Treatment Market Share by Players (2015-2020)
Table 22. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2019)
Table 23. Global Diabetes Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Diabetes Treatment Product Solution and Service
Table 26. Date of Enter into Diabetes Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Diabetes Treatment Market Size Share by Type (2015-2020)
Table 30. Global Diabetes Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Diabetes Treatment Market Size Share by Application (2015-2020)
Table 32. Global Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Diabetes Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Diabetes Treatment Market Share (2019-2020)
Table 36. North America Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Diabetes Treatment Market Share by Type (2015-2020)
Table 38. North America Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Diabetes Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Diabetes Treatment Market Share (2019-2020)
Table 42. Europe Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Diabetes Treatment Market Share by Type (2015-2020)
Table 44. Europe Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Diabetes Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Diabetes Treatment Market Share (2019-2020)
Table 48. China Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Diabetes Treatment Market Share by Type (2015-2020)
Table 50. China Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Diabetes Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Diabetes Treatment Market Share (2019-2020)
Table 54. Japan Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Diabetes Treatment Market Share by Type (2015-2020)
Table 56. Japan Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Diabetes Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Diabetes Treatment Market Share (2019-2020)
Table 60. Southeast Asia Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Diabetes Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Diabetes Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Diabetes Treatment Market Share (2019-2020)
Table 66. India Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Diabetes Treatment Market Share by Type (2015-2020)
Table 68. India Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Diabetes Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Diabetes Treatment Market Share (2019-2020)
Table 72. Central & South America Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Diabetes Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Diabetes Treatment Market Share by Application (2015-2020)
Table 76. Novo Nordisk Company Details
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Product
Table 79. Novo Nordisk Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 80. Novo Nordisk Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Product
Table 84. Bayer Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 85. Bayer Recent Development
Table 86. Teva Pharmaceuticals Company Details
Table 87. Teva Pharmaceuticals Business Overview
Table 88. Teva Pharmaceuticals Product
Table 89. Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 90. Teva Pharmaceuticals Recent Development
Table 91. Merck＆Company Company Details
Table 92. Merck＆Company Business Overview
Table 93. Merck＆Company Product
Table 94. Merck＆Company Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 95. Merck＆Company Recent Development
Table 96. Medtronic Company Details
Table 97. Medtronic Business Overview
Table 98. Medtronic Product
Table 99. Medtronic Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 100. Medtronic Recent Development
Table 101. Johnson＆Johnson Company Details
Table 102. Johnson＆Johnson Business Overview
Table 103. Johnson＆Johnson Product
Table 104. Johnson＆Johnson Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 105. Johnson＆Johnson Recent Development
Table 106. Home Diagnostics Company Details
Table 107. Home Diagnostics Business Overview
Table 108. Home Diagnostics Product
Table 109. Home Diagnostics Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 110. Home Diagnostics Recent Development
Table 111. Amylin Pharmaceuticals Business Overview
Table 112. Amylin Pharmaceuticals Product
Table 113. Amylin Pharmaceuticals Company Details
Table 114. Amylin Pharmaceuticals Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 115. Amylin Pharmaceuticals Recent Development
Table 116. Abbott Laboratories Company Details
Table 117. Abbott Laboratories Business Overview
Table 118. Abbott Laboratories Product
Table 119. Abbott Laboratories Revenue in Diabetes Treatment Business (2015-2020) (Million US$)
Table 120. Abbott Laboratories Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Treatment Market Share by Type: 2020 VS 2026
Figure 2. Insulin Features
Figure 3. Oral Hypoglycaemic Drugs Features
Figure 4. Non-Insulin Injectable Drugs Features
Figure 5. Others Features
Figure 6. Global Diabetes Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Personal Use Case Studies
Figure 9. Clinic Case Studies
Figure 10. Diabetes Treatment Report Years Considered
Figure 11. Global Diabetes Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Diabetes Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Diabetes Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Diabetes Treatment Market Share by Players in 2019
Figure 16. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Treatment Revenue in 2019
Figure 18. North America Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…- 不適切管理2型糖尿病治療の世界市場（～2026年） Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different …
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- 無針糖尿病治療の世界市場（～2026年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…
- 1型糖尿病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Type 1 Diabetes Drugs Market The global Type 1 Diabetes Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Type 1 Diabetes Drugs Scope and Market Size Type 1 Diabetes Drugs marke…